Quantum-Sis Platinum Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Companys 2023 Innovation by Design Awards
QSI Stock | USD 1.25 0.11 9.65% |
Under 59% of all QuantumSi's traders are looking to take a long position. The analysis of the overall investor sentiment regarding QuantumSi suggests that some traders are interested. QuantumSi's investing sentiment shows overall attitude of investors towards QuantumSi.
QuantumSi |
Quantum-Sis Platinum Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Companys 2023 Innovation by Design Awards
Read at businesswire.com
QuantumSi Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards QuantumSi can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
QuantumSi Fundamental Analysis
We analyze QuantumSi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QuantumSi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QuantumSi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
QuantumSi is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
QuantumSi Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with QuantumSi stock to make a market-neutral strategy. Peer analysis of QuantumSi could also be used in its relative valuation, which is a method of valuing QuantumSi by comparing valuation metrics with similar companies.
Peers
QuantumSi Related Equities
PASG | Passage Bio | 68.66 | ||||
NRIX | Nurix Therapeutics | 4.15 | ||||
BDTX | Black Diamond | 3.11 | ||||
MNOV | MediciNova | 2.99 | ||||
NTLA | Intellia Therapeutics | 2.70 | ||||
HRTX | Heron Therapeuti | 2.59 | ||||
EDIT | Editas Medicine | 1.82 | ||||
HOOK | Hookipa Pharma | 1.61 | ||||
ALEC | Alector | 1.57 | ||||
CRSP | Crispr Therapeutics | 0.65 | ||||
BEAM | Beam Therapeutics | 0.63 | ||||
ABOS | Acumen Pharmaceuticals | 0.44 | ||||
PRME | Prime Medicine, | 0.30 | ||||
CRBU | Caribou Biosciences | 0.45 | ||||
RNA | Avidity Biosciences | 0.69 | ||||
SEER | Seer | 1.20 | ||||
VERV | Verve Therapeutics | 2.94 | ||||
HCWB | HCW Biologics | 6.00 |
Complementary Tools for QuantumSi Stock analysis
When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |